People

Maxime Ranger

Biotechnology entrepreneur whom Genesys Capital appointed venture partner inJanuary2022. The current main manager directory omits him, and its announced future GP transition is not assumed completed. Neurenati’s current biography identifies him as its CEO and chair, with a Université Laval chemistry doctorate, Stanford postdoctoral fellowship and a joint UQAM/Paris-Dauphine executive MBA.